Publications by authors named "Karl Zimmerman"

Background: The hippocampus is a key site of atrophy in Alzheimer's disease (AD) and MRI derived estimates of hippocampal volume have been shown to be a robust biomarker of AD-related neurodegeneration. However, its application at the individual level is limited by the lack of reference standards from large normative datasets that can be applied across a wide range of settings. We aimed to investigate the utility of hippocampal volume centile scores adjusted for age, sex and total intracranial volume (TIV) derived from a normative data from 101,457 participants across the life course, as a biomarker of neurodegeneration in AD.

View Article and Find Full Text PDF
Article Synopsis
  • Traumatic brain injury (TBI) is prevalent among military personnel and is linked to an increased risk of dementia, with the ADVANCE-TBI study focusing on the neurological effects of major battlefield trauma using blood biomarkers like NfL and GFAP.
  • The study involved 1,145 servicemen and veterans, where TBI was identified in 16.9% of those exposed to major trauma, revealing significant mental health issues such as depression, anxiety, and PTSD, alongside impaired mobility and quality of life.
  • Elevated GFAP levels were found post-TBI, particularly in more severe cases, indicating a correlation with mental health challenges and increased unemployment, demonstrating the long-term impact of TBI on military personnel.
View Article and Find Full Text PDF
Article Synopsis
  • - The study explores the complex pathophysiology and outcomes of Traumatic Brain Injury (TBI), highlighting that current classifications do not adequately reflect the underlying biological processes involved.
  • - Using advanced proteomic techniques, researchers analyzed plasma samples from 88 participants to identify 16 proteins with significant expression differences in TBI patients compared to non-injured controls, focusing on various markers related to neurons, astrocytes, and inflammation.
  • - Their findings indicated correlations between specific plasma proteins and brain injury measures, suggesting that certain biomarkers like UCH-L1 and total tau could serve as potential indicators for TBI severity and progression.
View Article and Find Full Text PDF

Introduction: Although limited, recent research suggests that contact sport participation might have an adverse long-term effect on brain health. Further work is required to determine whether this includes an increased risk of neurodegenerative disease and/or subsequent changes in cognition and behaviour. The Advanced BiomaRker, Advanced Imaging and Neurocognitive Health Study will prospectively examine the neurological, psychiatric, psychological and general health of retired elite-level rugby union and association football/soccer players.

View Article and Find Full Text PDF

There is growing concern that elite rugby participation may negatively influence brain health, but the underlying mechanisms are unclear. Cortical thickness is a widely applied biomarker of grey matter structure, but there is limited research into how it may be altered in active professional rugby players. Cross-sectional MRI data from 44 active elite rugby players, including 21 assessed within 1 week of head injury, and 47 healthy controls were analysed.

View Article and Find Full Text PDF
Article Synopsis
  • Traumatic brain injury (TBI) does not significantly increase plasma levels of phosphorylated tau at serine-181 (p-tau181) within a year post-injury, unlike Alzheimer's disease where p-tau181 is elevated.* -
  • In contrast, other biomarkers like total-tau (t-tau), neurofilament light (NfL), and glial fibrillary acidic protein (GFAP) were significantly elevated following TBI and were predictive of brain atrophy rates.* -
  • The study highlights that while p-tau181 is a relevant marker in Alzheimer's, it doesn't serve as an indicator of neurodegeneration after moderate-to-severe TBI.*
View Article and Find Full Text PDF
Article Synopsis
  • Traumatic brain injury (TBI) is linked to chronic neurodegeneration, potentially due to systemic inflammation signaling the brain and activating microglia, which can lead to widespread brain damage.
  • The study, TBI-braINFLAMM, will analyze data from two major TBI research projects—CREACTIVE and BIO-AX-TBI—to assess the relationship between systemic inflammation, injury severity, and ongoing neurodegeneration.
  • Ethical approval has been obtained, and findings will be shared through peer-reviewed publications and conferences to enhance understanding and inform future research in this area.
View Article and Find Full Text PDF

Introduction: Outcomes of traumatic brain injury (TBI) are highly variable, with cognitive and psychiatric problems often present in survivors, including an increased dementia risk in the long term. Military personnel are at an increased occupational risk of TBI, with high rates of complex polytrauma including TBI characterising the UK campaign in Afghanistan. The ArmeD SerVices TrAuma and RehabilitatioN OutComE (ADVANCE)-TBI substudy will describe the patterns, associations and long-term outcomes of TBI in the established ADVANCE cohort.

View Article and Find Full Text PDF

Sports related head injuries can cause transient neurological events including loss of consciousness and dystonic posturing. However, it is unknown why head impacts that appear similar produce distinct neurological effects. The biomechanical effect of impacts can be estimated using computational models of strain within the brain.

View Article and Find Full Text PDF

Finite Element (FE) models of brain mechanics have improved our understanding of the brain response to rapid mechanical loads that produce traumatic brain injuries. However, these models have rarely incorporated vasculature, which limits their ability to predict the response of vessels to head impacts. To address this shortcoming, here we used high-resolution MRI scans to map the venous system anatomy at a submillimetre resolution.

View Article and Find Full Text PDF
Article Synopsis
  • GFAP is an important blood biomarker for neurological diseases, especially traumatic brain injury, but accurate detection in patient samples is currently lacking.
  • A new graphene field-effect transistor (GFET) biosensing method has been developed to quickly and sensitively detect GFAP in patient plasma, achieving very low limits of detection.
  • This GFET biosensor outperforms traditional methods like ELISA and other advanced technologies, offering faster results, cost-effectiveness, and ease of use, making it a promising option for point-of-care diagnostics.
View Article and Find Full Text PDF

To further fulfil their missions of promoting teaching, education and research in neurology and related clinical-academic disciplines, the Guarantors of Brain and the journal family invited delegates to the first Brain Conference in Spring of this year. This event aimed to deliver excellent teaching and scientific presentations across a broad spectrum of neuroscience fields, with the key aim of making the content as accessible as possible. We hoped to capitalize on the benefits of an online format, whilst trying to capture a little of the joy of the in-person meeting.

View Article and Find Full Text PDF

Axonal injury is a key determinant of long-term outcomes after traumatic brain injury (TBI) but has been difficult to measure clinically. Fluid biomarker assays can now sensitively quantify neuronal proteins in blood. Axonal components such as neurofilament light (NfL) potentially provide a diagnostic measure of injury.

View Article and Find Full Text PDF

Background: Transcranial direct current stimulation (tDCS) is a form of noninvasive brain stimulation whose potential as a cognitive therapy is hindered by our limited understanding of how participant and experimental factors influence its effects. Using functional MRI to study brain networks, we have previously shown in healthy controls that the physiological effects of tDCS are strongly influenced by brain state. We have additionally shown, in both healthy and traumatic brain injury (TBI) populations, that the behavioral effects of tDCS are positively correlated with white matter (WM) structure.

View Article and Find Full Text PDF

The recognition, diagnosis and management of mild traumatic brain injuries are difficult and confusing. It is unclear how the severity and number of injuries sustained relate to brain injuries, such as diffuse axonal injury, diffuse vascular injury and progressive neurodegeneration. Advances in neuroimaging techniques enable the investigation of neuropathologies associated with acute and long-term effects of injury.

View Article and Find Full Text PDF

New helmet technologies have been developed to improve the mitigation of traumatic brain injury (TBI) in bicycle accidents. However, their effectiveness under oblique impacts, which produce more strains in the brain in comparison with vertical impacts adopted by helmet standards, is still unclear. Here we used a new method to assess the brain injury prevention effects of 27 bicycle helmets in oblique impacts, including helmets fitted with a friction-reducing layer (MIPS), a shearing pad (SPIN), a wavy cellular liner (WaveCel), an airbag helmet (Hövding) and a number of conventional helmets.

View Article and Find Full Text PDF

Mild traumatic brain injury is a relatively common event in contact sports and there is increasing interest in the long-term neurocognitive effects. The diagnosis largely relies on symptom reporting and there is a need for objective tools to aid diagnosis and prognosis. There are recent reports that blood biomarkers could potentially help triage patients with suspected injury and normal CT findings.

View Article and Find Full Text PDF

Poor outcomes after traumatic brain injury (TBI) are common yet remain difficult to predict. Diffuse axonal injury is important for outcomes, but its assessment remains limited in the clinical setting. Currently, axonal injury is diagnosed based on clinical presentation, visible damage to the white matter or via surrogate markers of axonal injury such as microbleeds.

View Article and Find Full Text PDF
Article Synopsis
  • The study focuses on understanding and predicting cognitive impairments caused by traumatic brain injury (TBI) through biomarkers of axonal injury.
  • It involves a prospective longitudinal analysis across multiple European centers, aiming to recruit at least 250 patients and assess various fluid and neuroimaging biomarkers related to clinical outcomes.
  • Ethical approvals have been secured from various ethics committees across different European locations to ensure the study meets regulatory standards.
View Article and Find Full Text PDF

Traumatic brain injury is associated with elevated rates of neurodegenerative diseases such as Alzheimer's disease and chronic traumatic encephalopathy. In experimental models, diffuse axonal injury triggers post-traumatic neurodegeneration, with axonal damage leading to Wallerian degeneration and toxic proteinopathies of amyloid and hyperphosphorylated tau. However, in humans the link between diffuse axonal injury and subsequent neurodegeneration has yet to be established.

View Article and Find Full Text PDF

Non-invasive brain stimulation has been widely investigated as a potential treatment for a range of neurological and psychiatric conditions, including brain injury. However, the behavioural effects of brain stimulation are variable, for reasons that are poorly understood. This is a particular challenge for traumatic brain injury, where patterns of damage and their clinical effects are heterogeneous.

View Article and Find Full Text PDF

Traumatic brain injury (TBI) can trigger progressive neurodegeneration, with tau pathology seen years after a single moderate-severe TBI. Identifying this type of posttraumatic pathology in vivo might help to understand the role of tau pathology in TBI pathophysiology. We used flortaucipir positron emission tomography (PET) to investigate whether tau pathology is present many years after a single TBI in humans.

View Article and Find Full Text PDF

Background: Multiple sclerosis (MS) is characterised by a diffuse inflammatory response mediated by microglia and astrocytes. Brain translocator protein (TSPO) positron-emission tomography (PET) and [myo-inositol] magnetic resonance spectroscopy (MRS) were used together to assess this.

Objective: To explore the in vivo relationships between MRS and PET [C]PBR28 in MS over a range of brain inflammatory burden.

View Article and Find Full Text PDF

Motor-training software on tablets or smartphones (Apps) offer a low-cost, widely-available solution to supplement arm physiotherapy after stroke. We assessed the proportions of hemiplegic stroke patients who, with their plegic hand, could meaningfully engage with mobile-gaming devices using a range of standard control-methods, as well as by using a novel wireless grip-controller, adapted for neurodisability. We screened all newly-diagnosed hemiplegic stroke patients presenting to a stroke centre over 6 months.

View Article and Find Full Text PDF

Objective: We investigated whether intelligent advanced warnings of the end of green traffic signals help drivers negotiate the dilemma zone (DZ) at signalized intersections and sought to identify behavioral mechanisms for any warning-related benefits.

Background: Prior research suggested that warnings of end of green can increase slowing and stopping frequency given the DZ, but drivers may sometimes respond to warnings by speeding up.

Method: In two simulator studies, we compared six types of roadway or in-vehicle warnings with a no-warning control condition.

View Article and Find Full Text PDF